Does aspirin use influence hepatocellular carcinoma and cholangiocarcinoma prognosis?

Taylor and Francis Group, Expert Review of Anticancer Therapy, 9(22), p. 887-889, 2022

Journal article published in 2022 by Bernardo Stefanini

Distributing this paper is prohibited by the publisher

Full text: Unavailable

Preprint: archiving forbidden

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by